Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| A1M Pharma | 40,000 | net | 21 Sept 2023 | tx 2+40,000 |
| Klövern AB | -6,000 | net | 15 Jun 2021 | tx 1−6,000 |
| Devyser Diagnostics AB | 5,370 | net | 20 Feb 2025 | tx 3+15,370−10,000 |
| RhoVac AB | 2,300 | net | 11 Dec 2020 | tx 1+2,300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2025 | SALE | Devyser Diagnostics AB | 10,000 | 130.50 SEK | |
| 21 Sept 2023 | PURCHASE | A1M Pharma | 20,000 | 0.53 SEK | first after silence |
| 10 Dec 2021 | PURCHASE | Devyser Diagnostics AB | 12,000 | 80.00 SEK | |
| 10 Dec 2021 | PURCHASE | Devyser Diagnostics AB | 3,370 | 89.55 SEK | |
| 15 Jun 2021 | SALE | Klövern AB | 6,000 | 18.54 SEK | |
| 11 Dec 2020 | PURCHASE | RhoVac AB | 2,300 | 24.34 SEK | |
| 28 Sept 2020 | PURCHASE | A1M Pharma | 20,000 | 1.51 SEK |
1 purchase reported after at least 12 months of silence — most recent on 21 Sept 2023.